CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: docetaxel|DRUG: cyclophosphamide|DRUG: trastuzumab|DRUG: liposomal doxorubicin
Sponsor: National Cancer Institute, Naples